A Ordinas
Overview
Explore the profile of A Ordinas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
197
Citations
871
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hernandez M, Bozzo J, Tonda R, Galan A, Ordinas A, Escolar G
Int J Immunopathol Pharmacol
. 2003 Feb;
14(3):139-144.
PMID: 12604013
We analyzed how actin polymerization, CD11b expression and homotypic aggregation could be used as markers to study leukocyte activation. Leukocytes were obtained from blood anticoagulated with: citrate, unfractioned heparin (UH)...
12.
Munoz-Rodriguez F, Reverter J, Font J, Tassies D, Espinosa G, Cervera R, et al.
Lupus
. 2002 Dec;
11(11):730-5.
PMID: 12475003
Antiphospholipid antibodies (aPL) may induce acquired activated protein C resistance (acquired APCR). The role of acquired APCR in patients with systemic lupus erythematosus (SLE) is not well known. To evaluate...
13.
Bozzo J, Tonda R, Hernandez M, Alemany M, Galan A, Ordinas A, et al.
Biorheology
. 2002 May;
38(5-6):429-37.
PMID: 12016325
We investigated whether ghosts behaved similarly to intact erythrocytes to maintain regular primary hemostasis under flow conditions. To this end we performed perfusion experiments with whole blood in which erythrocytes...
14.
Serradell M, Diaz-Ricart M, Zurbano M, Lopez-Pedret J, Ordinas A, Escolar G, et al.
Nefrologia
. 2002 May;
22(1):33-41.
PMID: 11987682
We have investigated the ability of serum from uremic patients to modify the thrombogenic properties of the endothelium. The effect of the uremic media on the morphology of ECs, and...
15.
Galan A, Reverter J, Pino M, Vinas M, Bozzo J, Hernandez M, et al.
Vox Sang
. 2002 Apr;
82(3):113-8.
PMID: 11952983
Background And Objectives: We explored the effect on haemostasis of different factor IX (FIX) concentrates under thrombocytopenic conditions using an in vitro perfusion technique. Materials And Methods: A moderate experimental...
16.
Salmeron J, Lozano M, Agusti E, Mas A, Mazzara R, Marin P, et al.
Med Clin (Barc)
. 2002 Jan;
117(20):781-4.
PMID: 11784509
Background: Research aimed at developing artificial liver support systems has experienced a notable increase in the last decade. Hybrid systems including bioreactors containing hepatocytes which are perfused by liver failure...
17.
Lozano M, Oppenheimer F, Cofan F, Rosinyol L, Mazzara R, Escolar G, et al.
Thromb Res
. 2002 Jan;
104(6):405-11.
PMID: 11755950
Background: Muromonab-CD3 is a murine monoclonal antibody (MoAb) that is used in the prophylaxis and treatment of acute graft rejection. Activation of coagulation and fibrinolysis following anti-CD3 administration have been...
18.
Recombinant factor VIIa (Novoseven) restores deficient coagulation: experience from an ex vivo model
Galan A, Tonda R, Altisent C, Maragall S, Ordinas A, Escolar G
Semin Hematol
. 2001 Dec;
38(4 Suppl 12):10-4.
PMID: 11735104
The action of recombinant factor VIIa (rFVIIa) in coagulation deficiencies with increased risk of bleeding was investigated using in vitro perfusion. Blood samples were drawn from healthy donors, a patient...
19.
Serradell M, Diaz-Ricart M, Cases A, Zurbano M, Aznar-Salatti J, Lopez-Pedret J, et al.
Thromb Haemost
. 2001 Nov;
86(4):1099-105.
PMID: 11686330
We have investigated the ability of serum from uremic patients to modify the thrombogenic properties of the endothelium. The effects of uremic medium on the morphology of endothelial cells (ECs),...
20.
Espinosa G, Tassies D, Font J, Munoz-Rodriguez F, Cervera R, Ordinas A, et al.
Semin Arthritis Rheum
. 2001 Aug;
31(1):12-20.
PMID: 11503135
Objectives: To evaluate the prevalence of thrombophilic risk factors known to induce intravascular clotting and to assess their relationship with ischemic manifestations in giant cell arteritis (GCA). Methods: Eighty consecutive...